Published in Front Med (Lausanne) on June 12, 2017
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
The microRNA Registry. Nucleic Acids Res (2004) 29.45
A uniform system for microRNA annotation. RNA (2003) 20.28
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature (2005) 17.17
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract (2011) 15.13
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Treatment of HCV infection by targeting microRNA. N Engl J Med (2013) 9.91
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A (2008) 9.86
A global clinical measure of fitness and frailty in elderly people. CMAJ (2005) 8.99
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A (2007) 7.93
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59
RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol (2006) 6.81
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
Aortic stiffness, blood pressure progression, and incident hypertension. JAMA (2012) 6.01
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res (2007) 5.67
MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res (2007) 5.65
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol (2012) 5.12
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res (2010) 5.08
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res (2009) 4.88
Clustering and conservation patterns of human microRNAs. Nucleic Acids Res (2005) 4.79
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
MicroRNA profiling: approaches and considerations. Nat Rev Genet (2012) 4.39
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature (2011) 4.34
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab (2008) 4.34
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest (2011) 4.21
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
MicroRNAs 103 and 107 regulate insulin sensitivity. Nature (2011) 3.98
Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol (2014) 3.97
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res (2008) 3.96
miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A (2009) 3.89
Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol (2013) 3.85
Desperately seeking microRNA targets. Nat Struct Mol Biol (2010) 3.85
MiR423-5p as a circulating biomarker for heart failure. Circ Res (2010) 3.83
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res (2009) 3.53
Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res (2002) 3.51
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev (2000) 3.40
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation (2009) 3.19
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem (2011) 3.15
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A (2010) 2.58
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study. Circulation (2015) 2.48
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature (2011) 2.47
microRNA-34c is a novel target to treat dementias. EMBO J (2011) 2.44
The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med (2008) 2.34
miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell (2010) 2.31
Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a. Circulation (2011) 2.29
Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods (2012) 2.25
Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci (2010) 2.24
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes (2008) 2.23
The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol (1997) 2.18
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther (2006) 2.07
MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation (2010) 2.07
MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation (2009) 2.05
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol (2010) 2.01
Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res (2013) 2.01
MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res (2011) 2.01
miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet (2010) 1.97
Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension (2012) 1.92
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res (2009) 1.91
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest (2005) 1.89
Current views on type 2 diabetes. J Endocrinol (2009) 1.88
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res (2008) 1.87
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell (2011) 1.84
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest (2012) 1.84
Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity? Biotechnol Lett (2010) 1.84
Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail (2009) 1.83
Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci (2012) 1.82
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A (2012) 1.72
Ageing as a risk factor for disease. Curr Biol (2012) 1.71
Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol (2013) 1.69
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation (2015) 1.66
Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res (2013) 1.62
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci (2013) 1.61
Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation. Heart Rhythm (2013) 1.59
MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun (2010) 1.58
Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis (2011) 1.58
miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol (2011) 1.55
Circulating miRNAs: cell-cell communication function? Front Genet (2013) 1.55
Oxidative stress and hypertension: current concepts. Curr Hypertens Rep (2010) 1.54
The anti-ageing molecule sirt1 mediates beneficial effects of cardiac rehabilitation. Immun Ageing (2017) 0.75
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives. J Diabetes Res (2017) 0.75